newsfilter
← Latest News
Business Wire·

Revvity Announces Program to Revolutionize the Early Detection of Type 1 Diabetes

Initiative spans an IVD assay and a new Revvity Omics lab-developed test to expand clinical testing for early-stage disease screening Revvity, Inc. (NYSE:RVTY) today announced a program for expansion of its type 1